Malignant Peritoneal Neoplasm Completed Phase 2 Trials for Topotecan (DB01030)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00061308Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal CancerTreatment
NCT00343044Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn CancersTreatment